Featured Research

from universities, journals, and other organizations

Discovery Of Protein Controlling Fat Cell Development May Lead To Treatments For Obesity, Related Diseases, National Jewish And Veteran’s Affairs Researchers Find

Date:
January 13, 2000
Source:
National Jewish Medical And Research Center
Summary:
New ways of regulating a protein that binds to DNA in fat cells could lead to treatments for obesity, diabetes and heart disease in the future.

DENVER -- New ways of regulating a protein that binds to DNA in fat cells could lead to treatments for obesity, diabetes and heart disease in the future. Researchers have long known that obesity can result from fat cells increasing in volume--recent studies suggest that fat cells also increase in number--although until this discovery it was unknown what regulated the development of new fat cells. Understanding these controls may be key to the treatment of obesity.

“This protein, CREB, is vital in the creation and maintenance of fat cell development,” said Dwight J. Klemm, Ph.D., associate professor at National Jewish Medical and Research Center and lead author of the article announcing the finding in the February issue of the prestigious scientific journal, Molecular and Cellular Biology.

Researchers at National Jewish and the Denver Veteran’s Affairs Medical Center have discovered a new way to control fat cell development, which could have important implications for the treatment and management of obesity and related diseases, like heart disease and diabetes. The discovery is the culmination of more than 3 years of research into the behavior of fat cells, and the agents that control their growth and development.

“Although much of society believes that all fat is bad, most fat cells are an important component in the regulation of the body’s metabolism,” said Jane E.B. Reusch, M.D., assistant professor of Medicine at the University of Colorado Health Sciences Center and Denver Veteran’s Affairs Medical Center and co-author of the article. “For example, mature fat cells tell your brain you don’t need to eat. This message gets misinterpreted in obesity.”

Immature fat cells play a role in causing obesity by sending signals to the brain that a person is hungry. In people who are obese, fat cells become stuck in an immature state that doesn’t seem to decrease appetite as effectively, causing the body to create additional fat cells. Using a negative version of cyclic adenosine monophosphate response element binding protein (CREB), researchers were able to regulate fat cell development by inserting the protein into fat cell DNA. When negative CREB is inserted into fat cells it prevents normal CREB from binding to DNA in the fat cell. By doing this, the development of new fat cells can be inhibited.

“Fat cell development is an intensive area of research in obesity,” Dr. Klemm said. “This research also has potentially substantial benefits for people with diabetes and heart disease.”

Obesity is the result of numerous and interacting behavioral, physiological and biochemical factors, and is a major health concern in the United States and other nations. More than 33 percent of all Americans are overweight, and excess body fat contributes to the development and seriousness of other diseases, such as heart disease and diabetes.

“We are very excited about this discovery because understanding that this protein controls fat cell development could help us develop new strategies to treat obesity and related diseases,” Dr. Reusch said.

Researchers now will begin using CREB to treat obesity in laboratory animals in an effort to discover ways the protein can be safely and effectively used in medical treatments for humans.

The Number 1 Respiratory Hospital in the U.S. for Two Consecutive Years, U.S. News & World Report, 1998-2000.

Web site: http://www.nationaljewish.org/pa


Story Source:

The above story is based on materials provided by National Jewish Medical And Research Center. Note: Materials may be edited for content and length.


Cite This Page:

National Jewish Medical And Research Center. "Discovery Of Protein Controlling Fat Cell Development May Lead To Treatments For Obesity, Related Diseases, National Jewish And Veteran’s Affairs Researchers Find." ScienceDaily. ScienceDaily, 13 January 2000. <www.sciencedaily.com/releases/2000/01/000112151359.htm>.
National Jewish Medical And Research Center. (2000, January 13). Discovery Of Protein Controlling Fat Cell Development May Lead To Treatments For Obesity, Related Diseases, National Jewish And Veteran’s Affairs Researchers Find. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2000/01/000112151359.htm
National Jewish Medical And Research Center. "Discovery Of Protein Controlling Fat Cell Development May Lead To Treatments For Obesity, Related Diseases, National Jewish And Veteran’s Affairs Researchers Find." ScienceDaily. www.sciencedaily.com/releases/2000/01/000112151359.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins